SCHEMBL3402895

SCHEMBL3402895

CNc1nc(-c2nc(N3CC[C@@H](NC(=O)c4[nH]c(C)c(Cl)c4Cl)[C@@H](OC)C3)sc2C(=O)OC)c(C(=O)OC)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399966 0.94 — —
SCHEMBL3398942 0.91 — —
SCHEMBL3397913 0.90 — —
SCHEMBL3402890 0.90 ABCC2 (0.62) —
SCHEMBL3404597 0.88 — —
SCHEMBL3404108 0.87 ABCC2 (0.67) —
SCHEMBL3400886 0.86 — —
SCHEMBL15012671 0.85 ABCC2 (0.70) —
SCHEMBL3406562 0.85 ABCC2 (0.65) —
SCHEMBL3406362 0.85 ABCC2 (0.64) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2158199-B1 PIPERIDINE COMPOUNDS AND USES THEREOF ASTRAZENECA AB (SE) 2010-11-17 — — EP claimed
US-20080312255-A1 PIPERDINE COMPOUNDS AND USES THEREOF-911 ASTRAZENECA AB (SE) 2008-12-18 — — US claimed
EP-2158199-B1 PIPERIDINE COMPOUNDS AND USES THEREOF ASTRAZENECA AB (SE) 2010-11-17 — — EP disclosed
Send feedback